Anil Malhotra

Summary

Affiliation: Long Island Jewish Medical Center
Country: USA

Publications

  1. doi request reprint Genes and schizophrenia: from a festschrift seminar honoring william T. Carpenter jr, MD
    Anil K Malhotra
    To whom correspondence should be addressed Division of Psychiatry Research, The Zucker Hillside Hospital, 75 59 263rd Street, Glen Oaks, NY 11004, US tel 718 470 8012, fax 718 343 1659, E mail
    Schizophr Bull 40:S117-22. 2014
  2. doi request reprint Safety profile of iloperidone in the treatment of schizophrenia
    Navin V Dargani
    The Zucker Hillside Hospital, Hofstra North Shore LIJ School of Medicine, 75 59 263rd Street, Glen Oaks, NY 11004, USA 1 718 470 8012 1 718 343 1659
    Expert Opin Drug Saf 13:241-6. 2014
  3. ncbi request reprint Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain
    Anil K Malhotra
    Psychiatry Research, Zucker Hillside Hospital, 75 59 263rd St, Glen Oaks, NY 11004, USA
    Arch Gen Psychiatry 69:904-12. 2012
  4. doi request reprint Pharmacogenetics in psychiatry: translating research into clinical practice
    A K Malhotra
    Division of Psychiatry Research, The Zucker Hillside Hospital, Glen Oaks, NY 11004, USA
    Mol Psychiatry 17:760-9. 2012
  5. pmc Implications for health and disease in the genetic signature of the Ashkenazi Jewish population
    Saurav Guha
    Department of Psychiatry, Division of Research, The Zucker Hillside Hospital Division of the North Shore Long Island Jewish Health System, 75 59, 263rd St Glen Oaks, NY 11004, USA
    Genome Biol 13:R2. 2012
  6. ncbi request reprint No evidence for phenotypic variation between probands in case-control versus family-based association studies of schizophrenia
    Anil K Malhotra
    Hillside Hospital, Psychiatry Research, Glen Oaks, New York 11004, USA
    Am J Med Genet 114:509-11. 2002
  7. ncbi request reprint A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition
    Anil K Malhotra
    Unit of Molecular Psychiatry, Hillside Hospital, Glen Oaks, NY 11004, USA
    Am J Psychiatry 159:652-4. 2002
  8. pmc Individualizing antipsychotic drug therapy in schizophrenia: the promise of pharmacogenetics
    Charles U Nnadi
    Zucker Hillside Hospital, Glen Oaks, NY 11004, USA
    Curr Psychiatry Rep 9:313-8. 2007
  9. ncbi request reprint Genomics and the future of pharmacotherapy in psychiatry
    Anil K Malhotra
    Division of Psychiatry Research, The Zucker Hillside Hospital, Glen Oaks, NY 11004, USA
    Int Rev Psychiatry 19:523-30. 2007
  10. ncbi request reprint Ziprasidone-induced cognitive enhancement in schizophrenia: specificity or pseudospecificity?
    Anil K Malhotra
    Division of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, and Albert Einstein College of Medicine, United States
    Schizophr Res 87:181-4. 2006

Collaborators

Detail Information

Publications60

  1. doi request reprint Genes and schizophrenia: from a festschrift seminar honoring william T. Carpenter jr, MD
    Anil K Malhotra
    To whom correspondence should be addressed Division of Psychiatry Research, The Zucker Hillside Hospital, 75 59 263rd Street, Glen Oaks, NY 11004, US tel 718 470 8012, fax 718 343 1659, E mail
    Schizophr Bull 40:S117-22. 2014
    ..In this article, I will briefly summarize some of the major findings emerging from these lines of research and highlight the role of the Dr Carpenter and his colleagues at the MPRC in this area. ..
  2. doi request reprint Safety profile of iloperidone in the treatment of schizophrenia
    Navin V Dargani
    The Zucker Hillside Hospital, Hofstra North Shore LIJ School of Medicine, 75 59 263rd Street, Glen Oaks, NY 11004, USA 1 718 470 8012 1 718 343 1659
    Expert Opin Drug Saf 13:241-6. 2014
    ..The purpose of this article is to describe the safety profile of iloperidone and its clinical implications...
  3. ncbi request reprint Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain
    Anil K Malhotra
    Psychiatry Research, Zucker Hillside Hospital, 75 59 263rd St, Glen Oaks, NY 11004, USA
    Arch Gen Psychiatry 69:904-12. 2012
    ..Unfortunately, SGAs are often associated with substantial weight gain, with no means to predict which patients are at greatest risk...
  4. doi request reprint Pharmacogenetics in psychiatry: translating research into clinical practice
    A K Malhotra
    Division of Psychiatry Research, The Zucker Hillside Hospital, Glen Oaks, NY 11004, USA
    Mol Psychiatry 17:760-9. 2012
    ..Taken together, these data provide insights into the design and methodological considerations that may enhance the potential for clinical utility of PGx studies...
  5. pmc Implications for health and disease in the genetic signature of the Ashkenazi Jewish population
    Saurav Guha
    Department of Psychiatry, Division of Research, The Zucker Hillside Hospital Division of the North Shore Long Island Jewish Health System, 75 59, 263rd St Glen Oaks, NY 11004, USA
    Genome Biol 13:R2. 2012
    ..Comparison of the genotyping data with that of neighboring European and Asian populations enabled the Ashkenazi Jewish-specific component of the variance to be characterized with respect to disease-relevant alleles and pathways...
  6. ncbi request reprint No evidence for phenotypic variation between probands in case-control versus family-based association studies of schizophrenia
    Anil K Malhotra
    Hillside Hospital, Psychiatry Research, Glen Oaks, New York 11004, USA
    Am J Med Genet 114:509-11. 2002
    ....
  7. ncbi request reprint A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition
    Anil K Malhotra
    Unit of Molecular Psychiatry, Hillside Hospital, Glen Oaks, NY 11004, USA
    Am J Psychiatry 159:652-4. 2002
    ..The COMT gene contains a functional polymorphism, Val158Met, that exerts a fourfold effect on enzyme activity. The current study investigated whether prefrontal cognition varies with COMT genotype...
  8. pmc Individualizing antipsychotic drug therapy in schizophrenia: the promise of pharmacogenetics
    Charles U Nnadi
    Zucker Hillside Hospital, Glen Oaks, NY 11004, USA
    Curr Psychiatry Rep 9:313-8. 2007
    ....
  9. ncbi request reprint Genomics and the future of pharmacotherapy in psychiatry
    Anil K Malhotra
    Division of Psychiatry Research, The Zucker Hillside Hospital, Glen Oaks, NY 11004, USA
    Int Rev Psychiatry 19:523-30. 2007
    ..These increasingly comprehensive approaches should provide informative data on the genes associated with psychotropic drug response, a critical step towards the ultimate goal of 'personalized' medicine...
  10. ncbi request reprint Ziprasidone-induced cognitive enhancement in schizophrenia: specificity or pseudospecificity?
    Anil K Malhotra
    Division of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, and Albert Einstein College of Medicine, United States
    Schizophr Res 87:181-4. 2006
    ..We tested the hypothesis that ziprasidone improves cognition in the absence of clinical improvement...
  11. ncbi request reprint Pharmacogenetics of psychotropic drug response
    Anil K Malhotra
    Department of Psychiatry Research, Zucker Hillside Hospital, 75 59 263rd St, Glen Oaks, NY 11004, USA
    Am J Psychiatry 161:780-96. 2004
    ..These pharmacogenetic strategies offer the prospect of identifying biological predictors of psychotropic drug response and could provide the means of determining the molecular substrates of drug efficacy and drug-induced adverse events...
  12. ncbi request reprint Candidate gene studies of antipsychotic drug efficacy and drug-induced weight gain
    Anil K Malhotra
    Department of Psychiatry Research, Albert Einstein College of Medicine, Zucker Hillside Hospital, 57 59 263rd Street, Glen Oaks, NY 11004, USA
    Neurotox Res 6:51-6. 2004
    ....
  13. pmc Emotion-based decision-making in healthy subjects: short-term effects of reducing dopamine levels
    Serge Sevy
    Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, Yeshiva University, Bronx, and Psychiatry Research Department, The Zucker Hillside Hospital, Glen Oaks, NY, USA
    Psychopharmacology (Berl) 188:228-35. 2006
    ..So far, it is unclear what aspects of addictive behaviors are related to a dopaminergic dysfunction...
  14. ncbi request reprint Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia
    T Lencz
    Department of Psychiatry Research, The Zucker Hillside Hospital, Division of the North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    Mol Psychiatry 12:572-80. 2007
    ..The presence of cytokine receptor abnormalities in schizophrenia may help explain prior epidemiologic data relating the risk for this illness to altered rates of autoimmune disorders, prenatal infection and familial leukemia...
  15. ncbi request reprint Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation
    P R Szeszko
    Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY, USA
    Mol Psychiatry 10:631-6. 2005
    ..These findings implicate genetic involvement of BDNF in variation of human hippocampal volume and suggest that this effect may be greater among patients compared to healthy volunteers...
  16. ncbi request reprint Impaired attention as an endophenotype for molecular genetic studies of schizophrenia
    B A Cornblatt
    Hillside Hospital, Psychiatry Research, Glen Oaks, New York 11004, USA
    Am J Med Genet 105:11-5. 2001
    ....
  17. pmc Runs of homozygosity reveal highly penetrant recessive loci in schizophrenia
    Todd Lencz
    Department of Psychiatry Research, Zucker Hillside Hospital, North Shore Long Island Jewish Health System, 75 59 263rd Street, Glen Oaks, NY 11004, USA
    Proc Natl Acad Sci U S A 104:19942-7. 2007
    ..Other risk ROHs feature haplotypes that are also common in healthy individuals, possibly indicating a source of balancing selection...
  18. ncbi request reprint Disrupted in schizophrenia 1 genotype and positive symptoms in schizophrenia
    Pamela DeRosse
    Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, New York 11004, USA
    Biol Psychiatry 61:1208-10. 2007
    ....
  19. pmc DTNBP1 genotype influences cognitive decline in schizophrenia
    Katherine E Burdick
    Division of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, United States
    Schizophr Res 89:169-72. 2007
    ..The current study assessed the relationship between intellectual decline in schizophrenia and genetic variation in dysbindin-1 (DTNBP1)...
  20. ncbi request reprint Increased stress and smaller anterior hippocampal volume
    Philip R Szeszko
    Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, New York 11004, USA
    Neuroreport 17:1825-8. 2006
    ..Our results may also have implications for neuropsychiatric disorders that have implicated stress and hippocampal abnormalities in their pathogenesis...
  21. ncbi request reprint Anterior cingulate grey-matter deficits and cannabis use in first-episode schizophrenia
    Philip R Szeszko
    Zucker Hillside Hospital, Psychiatry Research, 75 59 263rd Street, Glen Oaks, NY 11004, USA
    Br J Psychiatry 190:230-6. 2007
    ..Despite the high prevalence of cannabis use in schizophrenia, few studies have examined the potential relationship between cannabis exposure and brain structural abnormalities in schizophrenia...
  22. pmc Patterns of stress in schizophrenia
    Julia D Betensky
    Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    Psychiatry Res 160:38-46. 2008
    ....
  23. ncbi request reprint Early identification and high-risk strategies for bipolar disorder
    Christoph U Correll
    The Zucker Hillside Hospital, Psychiatry Research, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    Bipolar Disord 9:324-38. 2007
    ..To describe and compare the relative merits of different identification strategies for individuals at risk for bipolar disorder (BPD)...
  24. ncbi request reprint COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance
    Katherine E Burdick
    Department of Psychiatry Research, Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    Bipolar Disord 9:370-6. 2007
    ..A large body of evidence suggests that COMT is associated with cognitive performance in patients with schizophrenia and in healthy volunteers but there have been no reports of its relationship to cognition in BPD...
  25. ncbi request reprint Clinical and neuropsychological correlates of white matter abnormalities in recent onset schizophrenia
    Philip R Szeszko
    Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    Neuropsychopharmacology 33:976-84. 2008
    ..These abnormalities have clinical and neuropsychological correlates, which may be useful in further characterizing structure-function relations in schizophrenia and constraining neurobiological models of the disorder...
  26. pmc Analysis of TBX1 variation in patients with psychotic and affective disorders
    Birgit H Funke
    Harvard Partners Center for Genetics and Genomics, Boston, MA 02139, USA
    Mol Med 13:407-14. 2007
    ..Based on these results we conclude that TBX1 variation does not make a strong contribution to the genetic etiology of nonsyndromic forms of psychiatric disorders commonly seen in patients with 22q11DS...
  27. ncbi request reprint Clinical insights into pharmacogenetics and schizophrenia, part 2
    John M Kane
    Department of Psychiatry, Zucker Hillside Hospital, Glen Oaks, NY, USA
    J Clin Psychiatry 69:1006-13. 2008
  28. ncbi request reprint Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial
    Richard S E Keefe
    Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA
    Neuropsychopharmacology 33:1217-28. 2008
    ..A significant and surprisingly large placebo/practice effect was observed among placebo-treated patients, and is a serious consideration in future clinical trial study designs for potential cognitive enhancing compounds in schizophrenia...
  29. pmc Genetic variation in the DAOA gene complex: impact on susceptibility for schizophrenia and on cognitive performance
    Carolin Opgen-Rhein
    Division of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, New York 11004, United States
    Schizophr Res 103:169-77. 2008
    ..Our aim in this study was to investigate the relationship between DAOA variation and schizophrenia, and the influence of DAOA on cognitive performance...
  30. ncbi request reprint Early prediction of antipsychotic response in schizophrenia
    Christoph U Correll
    Department of Psychiatry Research, Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    Am J Psychiatry 160:2063-5. 2003
    ..The authors' goal was to examine the predictive value of early symptom changes indicating response to antipsychotic medication in schizophrenia...
  31. pmc Elucidating the relationship between DISC1, NDEL1 and NDE1 and the risk for schizophrenia: evidence of epistasis and competitive binding
    Katherine E Burdick
    Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    Hum Mol Genet 17:2462-73. 2008
    ..These data suggest that NDEL1 significantly influences risk for SZ via an interaction with DISC1. We propose a model where NDEL1 and NDE1 compete for binding with DISC1...
  32. ncbi request reprint Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?
    Terry E Goldberg
    Zucker Hillside Hospital, 7559 263rd Street, Glen Oaks, NY 11004, USA
    Arch Gen Psychiatry 64:1115-22. 2007
    ..However, none of these studies included healthy controls undergoing repeated testing to assess the possibility that improvements might reflect simple practice effects...
  33. pmc DISC1 is associated with prefrontal cortical gray matter and positive symptoms in schizophrenia
    Philip R Szeszko
    Feinstein Institute for Medical Research, Manhasset, NY, USA
    Biol Psychol 79:103-10. 2008
    ..Given that DISC1 plays a role in cerebral cortex development, polymorphisms in this gene may have relevance for neurobiological models of schizophrenia that have implicated cortical deficits in its pathophysiology...
  34. ncbi request reprint Cognitive dysfunction in bipolar disorder: future place of pharmacotherapy
    Katherine E Burdick
    Department of Psychiatry, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, New York 11004, USA
    CNS Drugs 21:971-81. 2007
    ..Finally, psychosocial intervention and/or cognitive remediation should be considered as alternatives to medications, although these techniques will also require additional systematic study...
  35. ncbi request reprint The FEZ1 gene shows no association to schizophrenia in Caucasian or African American populations
    Colin A Hodgkinson
    Section of Human Neurogenetics, Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, USA
    Neuropsychopharmacology 32:190-6. 2007
    ..Neuropsychopharmacology (2007) 32, 190-196. doi:10.1038/sj.npp.1301177; published online 16 August 2006...
  36. pmc Genetic association and brain morphology studies and the chromosome 8p22 pericentriolar material 1 (PCM1) gene in susceptibility to schizophrenia
    Hugh M D Gurling
    Molecular Psychiatry Laboratory, Department of Mental Health Sciences, University College London Medical School, Windeyer Institute of Medical Sciences, London, United Kingdom
    Arch Gen Psychiatry 63:844-54. 2006
    ..There is evidence of linkage to a schizophrenia susceptibility locus on chromosome 8p21-22 found by several family linkage studies...
  37. ncbi request reprint A prospective study of hyperprolactinemia in children and adolescents treated with atypical antipsychotic agents
    Ema Saito
    Department of Psychiatry Research, The Zucker Hillside Hospital, Long Island Jewish Medical Center, New Hyde Park, NY, USA
    J Child Adolesc Psychopharmacol 14:350-8. 2004
    ..We hypothesized: (1) risperidone would be associated with hyperprolactinemia most frequently, and (2) postpubertal females may be at higher risk of prolactin elevation and associated adverse effects...
  38. pmc Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder
    Colin A Hodgkinson
    Section of Human Neurogenetics and Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, Rockville, MD, USA
    Am J Hum Genet 75:862-72. 2004
    ..These data support the idea that these apparently distinct disorders have at least a partially convergent etiology and that variation at the DISC1 locus predisposes individuals to a variety of psychiatric disorders...
  39. pmc Association of the DTNBP1 locus with schizophrenia in a U.S. population
    Birgit Funke
    Harvard Medical School Partners Center for Genetics and Genomics, Boston, MA 02115, USA
    Am J Hum Genet 75:891-8. 2004
    ..005). Our study provides further evidence for a role of the DTNBP1 gene in the genetic etiology of schizophrenia...
  40. ncbi request reprint Effects of serotonin transporter promoter polymorphisms on serotonin function
    Gwenn S Smith
    Department of Psychiatry, The Zucker Hillside Hospital, Glen Oaks, NY 11004, USA
    Neuropsychopharmacology 29:2226-34. 2004
    ....
  41. ncbi request reprint Pharmacogenetics of antipsychotic-induced weight gain
    Christoph U Correll
    Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    Psychopharmacology (Berl) 174:477-89. 2004
    ..To enhance power, future studies should pay close attention to population selection and avoidance/control of confounds, particularly past treatment exposure...
  42. ncbi request reprint Sex differences in frontal lobe white matter microstructure: a DTI study
    Philip R Szeszko
    Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, 75 59 263rd Street, Glen Oaks, NY 11004, USA
    Neuroreport 14:2469-73. 2003
    ..Our findings may be indicative of increased directional coherence and/or density of left hemisphere white matter fibers and a leftward asymmetry of this structural integrity among women compared to men...
  43. ncbi request reprint Smaller anterior hippocampal formation volume in antipsychotic-naive patients with first-episode schizophrenia
    Philip R Szeszko
    Department of Psychiatry Research, The Zucker Hillside Hospital, 75 59 263rd St, Glen Oaks, NY 11004, USA
    Am J Psychiatry 160:2190-7. 2003
    ..The authors investigated volumetric alterations of the anterior hippocampal formation in patients experiencing a first episode of schizophrenia relative to healthy comparison subjects...
  44. ncbi request reprint Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia
    Robert M Bilder
    Nathan S Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA
    Biol Psychiatry 52:701-7. 2002
    ....
  45. ncbi request reprint Discovery and utilization of haplotypes for pharmacogenetic studies of psychotropic drug response
    Maria C Athanasiou
    Genaissance Pharmaceuticals, Inc, New Haven, Connecticut 06511, USA
    Psychiatr Genet 12:89-96. 2002
    ..This approach has clear implications for the discovery of psychiatric disease-associated genes as well as for the development of safer, more efficacious psychiatric drugs...
  46. ncbi request reprint White matter abnormalities in first-episode schizophrenia or schizoaffective disorder: a diffusion tensor imaging study
    Philip R Szeszko
    The Zucker Hillside Hospital, Department of Psychiatry Research, 75 59 263rd St, Glen Oaks, NY 11004, USA
    Am J Psychiatry 162:602-5. 2005
    ..The goal of this study was to investigate brain white matter abnormalities by using diffusion tensor imaging in patients with schizophrenia or schizoaffective disorder close to illness onset...
  47. ncbi request reprint White matter abnormalities in obsessive-compulsive disorder: a diffusion tensor imaging study
    Philip R Szeszko
    Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    Arch Gen Psychiatry 62:782-90. 2005
    ....
  48. pmc Genetics and psychopharmacology: prospects for individualized treatment
    Charles U Nnadi
    Department of Psychiatry Research, Zucker Hillside Hospital, Glen Oaks, New York, USA
    Essent Psychopharmacol 6:193-208. 2005
    ..This research promises to strengthen the accuracy, effectiveness, safety, and cost of our psychopharmacological practices...
  49. ncbi request reprint COMT genotype and manic symptoms in schizophrenia
    Pamela DeRosse
    Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, 75 59 263rd Street, Glen Oaks, NY 11004, and Harvard Partners Center for Genetics and Genomics, Boston, MA, United States
    Schizophr Res 87:28-31. 2006
    ..These data suggest that the effect of COMT variation may be associated with comorbid manic symptoms in SZ...
  50. ncbi request reprint The Third Annual Pharmacogenetics in Psychiatry Meeting, 2004
    Youssef Hassoun
    Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    Psychiatr Genet 15:155-6. 2005
  51. ncbi request reprint Interferon-induced obsessive-compulsive disorder
    Pamela DeRosse
    Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    Gen Hosp Psychiatry 28:357-8. 2006
  52. ncbi request reprint Neurocognition as a stable endophenotype in bipolar disorder and schizophrenia
    Katherine E Burdick
    Bipolar Disorders Research Program, Department of Psychiatry Research, Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, New York 11004, USA
    J Nerv Ment Dis 194:255-60. 2006
    ..These preliminary findings suggest that neurocognitive domains appear longitudinally stable across broad domains in schizophrenia. In contrast, stable functioning may be more limited to attentional domains in bipolar disorder...
  53. ncbi request reprint Dysbindin genotype and negative symptoms in schizophrenia
    Pamela DeRosse
    Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, NY 11004, USA
    Am J Psychiatry 163:532-4. 2006
    ....
  54. ncbi request reprint DRD2 promoter region variation as a predictor of sustained response to antipsychotic medication in first-episode schizophrenia patients
    Todd Lencz
    Department of Psychiatry Research, The Zucker Hillside Hospital, Glen Oaks, NY 11004, USA
    Am J Psychiatry 163:529-31. 2006
    ....
  55. ncbi request reprint Genetic variation in DTNBP1 influences general cognitive ability
    Katherine E Burdick
    Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Albert Einstein College of Medicine, Glen Oaks, NY 11004, USA
    Hum Mol Genet 15:1563-8. 2006
    ..These data suggest that DTNBP1 genetic variation influences human intelligence...
  56. ncbi request reprint Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents
    Christoph U Correll
    The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, 75 59 263rd Street, Glen Oaks, NY 11004, USA
    Child Adolesc Psychiatr Clin N Am 15:177-206. 2006
    ..This article presents an overview of SGA-related side effects in children and adolescents and strategies to monitor health outcomes effectively in youngsters receiving SGAs...
  57. ncbi request reprint DISC1 and neurocognitive function in schizophrenia
    Katherine E Burdick
    Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore Long Island Jewish Health System, Glen Oaks, New York, USA
    Neuroreport 16:1399-402. 2005
    ..These data suggest that DISC1 is associated with neurocognitive functioning in schizophrenia...
  58. ncbi request reprint Metabolism and biochemical effects of nicotine for primary care providers
    Christine N Metz
    Laboratory of Medicinal Biochemistry, Center for Patient Oriented Research, North Shore Long Island Jewish Research Institute, 350 Community Drive, Manhasset, NY 11030, USA
    Med Clin North Am 88:1399-413, ix. 2004
    ..This article covers the absorption and metabolism of nicotine, nicotine toxicity, pharmacologic effects of nicotine, nicotine-drug interactions, and the use of nicotine for the treatment of disease...
  59. ncbi request reprint Amphetamine-induced dopamine release and post-synaptic specific binding in patients with mild tardive dyskinesia
    Caleb M Adler
    Experimental Therapeutics Branch, National Institute of Mental Health NIH, Bethesda, MD, USA
    Neuropsychopharmacology 26:295-300. 2002
    ..More research is needed to unravel the neurobiology of this debilitating disorder...
  60. ncbi request reprint Pharmacogenetics in psychiatry satellite meeting at the American College of Neuropsychopharmacology, 2000
    Anil K Malhotra
    Hillside Hospital, Unit of Molecular Psychiatry, Glen Oaks, NY, USA
    Neuropsychopharmacology 26:123-7. 2002

Research Grants5

  1. CLINICAL TRIALS IN SCHIZOPHRENIA--MOLECULAR APPROACHES
    Anil Malhotra; Fiscal Year: 2003
    ..abstract_text> ..
  2. Genetic Variation and Functional Disability in Schizophrenia
    Anil Malhotra; Fiscal Year: 2007
    ....
  3. Genetic Variation and Functional Disability in Schizophrenia
    Anil K Malhotra; Fiscal Year: 2010
    ....